Industries > Pharma > Top 25 Antibiotic Drugs Manufacturers 2018

Top 25 Antibiotic Drugs Manufacturers 2018

US, Europe, Japan, Cephalosporins, Penicillins, Fluoroquinolones, Macrolides, Carbapenems, Others

PUBLISHED: 12 June 2018
PAGES: 250
PRODUCT CODE: PHA0316

Clear
WOOCS 2.2.1

Visiongain forecasts the antibiotic drugs market to increase to $ 43,841.7m in 2022. The market is estimated to grow at a CAGR of 3.4% between 2022 and 2028. In 2017, Pfizer held the largest market share of the antibiotic drugs market.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 250-page report you will receive 181 tables and 111 figures– all unavailable elsewhere.

The 250-page report provides clear detailed insight into the top 25 antibiotic drugs manufacturers. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

Global Antibiotic Drugs Market Forecast from 2018-2028, further segmented by type:
• Cephalosporins
• Penicillins
• Fluoroquinolones
• Macrolides
• Carbapenems
• Others

Top 25 Antibiotic Drugs Manufacturers 2018

• This report provides analysis of the leading antibiotic drugs manufacturers in the US, including forecasts from 2018-2028 of the company’s antibiotic drugs revenues, where possible:
• Pfizer: Sulperazon, Unasyn, Zithromax, Dalacin, Merrem/Meropen, Zyvox, Tygacil, Others
• Merck & Co.: Cubicin, Invanz, Avelox, Primaxin, Others
• Johnson & Johnson: Zeftera, Sirturo, Others
• Cubist Pharmaceuticals: Cubicin, Sivextro Oral
• Abbott Laboratories: Baxin, Others
• Eli Lilly & Co.: Vancocin, Ceclor
• Melinta Therapeutics, Inc: Orbactiv, Others

• This report provides analysis of the leading antibiotic drugs manufacturers in Europe, including forecasts from 2018-2028 of the company’s antibiotic drugs revenues, where possible:
• Novartis: Vigamox, Ciprodex, TOBI Podhaler, Cubicin
• GlaxoSmithKline: Ceftin/Zinnat, Augmentin IR, Amoxil, Others
• Bayer: Avelox, Cipro/Cirpobay
• Allergan: Zinforo/Teflaro, Dalbavancin, Others
• Roche: Rocephin
• Sanofi: Targocid, Others
• STADA Arzneimittel: Amoxicillin, Diclofenac Sodium

• This report provides analysis of the leading antibiotic drugs manufacturers in Japan, including forecasts from 2018-2028 of the company’s antibiotic drugs revenues, where possible:
• Shionogi & Co., Ltd.: Flomox/Flumarin, Others
• Taisho Pharmaceutical Holdings: Geninax, Biaxin/Clarith, Zosyn/Tazocin
• Daiichi Sankyo: Cravit, Levaquin, Others
• Meiji Holdings Company, Ltd.: Meiact/Spectracef, Others
• Astellas Pharma: Dificid, Others

• This report provides analysis of the leading antibiotic drugs manufacturers in other countries, including forecasts from 2018-2028 of the company’s antibiotic drugs revenue, where possible:
• Sun Pharmaceutical Industries: Ciprofloxacin Hydrochloride, Others
• Cipla: Amoxicillin, Others
• Lupin: Cefixime, Cephalexin, Others
• Shanghai Pharmaceuticals Holding: Cefotaxime Sodium, Cefotiam Hydrochloride, Ceftriaxone Sodium
• Dr. Reddy’s Laboratories: Cefotaxime Sodium, Cefotiam Hydrochloride, Ceftriaxone Sodium
• TaiGen Biotechnology: Taigexyn

Visiongain’s study is intended for anyone requiring commercial analyses for the top 25 antibiotic drugs manufacturers. You find data, trends and predictions.

Buy our report today Top 25 Antibiotic Drugs Manufacturers 2018: US, Europe, Japan, Cephalosporins, Penicillins, Fluoroquinolones, Macrolides, Carbapenems, Others.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Top 25 Antibiotic Drugs Manufacturers 2018


Download sample pages

Complete the form below to download your free sample pages for Top 25 Antibiotic Drugs Manufacturers 2018


Latest Pharma news

Visiongain Publishes Cancer Diagnostics Market Report 2021-2031

Major investments have been made by companies in the cancer diagnostics industry in the past few years to develop novel tests to capitalize on the opportunities in the untapped market.

19 April 2021

READ

Visiongain Publishes Food for Special Medical Purpose (FSMP) Market Report 2020-2030

The food for special medical purpose (FSMP) market growth can be attributed to the growing prevalence of metabolic diseases, growing consumer unhealthy lifestyle, and surge in demand from emerging economies such as Asia Pacific, Middle East & Africa, Latin America, and others.

12 April 2021

READ

Visiongain Publishes Cell-Based Assays Market Report to 2030

Growing incidence of chronic diseases; increasing R&D investment for drug discovery research and Growing Adoption of High-Throughput Screening Methodologies are some of the major factors that propel the market growth.

09 April 2021

READ

Visiongain Publishes Cancer Biologics Therapies Market Report 2021-2031

The main drivers for the growth include technological advancements in the development of novel biomarkers, rising preference for minimally or less invasive surgeries, increasing cancer awareness leading to growth in cancer cases, and growing disposable income in emerging economies.

06 April 2021

READ

Categories